What is the current stock price of Semantix, Inc. (STIX)?

As of the latest market data, Semantix, Inc. (STIX) is trading at $0.30. The stock has seen a loss of -17.36% today.

Does Semantix, Inc. (STIX) pay a dividend?

Based on current data, Semantix, Inc. does not have a confirmed active dividend policy.

What is the market cap of Semantix, Inc.?

The current market capitalization of Semantix, Inc. (STIX) is approximately unavailable.

STIX

Semantix, Inc.·Technology

0.30

17.355%(−0.06)

Market Closed

Last Updated: — ET

52W L: $0.0652W H: $4.74

STIX NEWS

businesswire.com

4d ago

Acadia Pharmaceuticals Announces DAYBUE® STIX (trofinetide) is Now Broadly Available in the United States for the Treatment of Rett Syndrome

SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced DAYBUE® STIX (trofinetide) for oral solution, a dye- and preservative-free powder formulation of trofinetide, is now broadly available in the United States for the treatment of Rett syndrome in adults and pediatric patients two years of age and older. The new formulation, approved by the U.S. Food and Drug Administration (FDA) in December 2025, is bioequivalent to the original DAYBUE® oral solution, deliverin.

Company Profile

Semantix Tecnologia Em Sistema de Informacao S.A. provides consulting, training, and support for big data solutions, data science, enterprise search, machine learning, and Internet of things. The company was incorporated in 2007 and is headquartered in São Paulo, Brazil.

Sector

Technology

Industry

Software - Application

Employees

IPO Date

2021-04-14

Beta

-0.37

Websitewww.semantix.com.br↗